Furthermore, we found that TGFBI may function as a key regulator in chemoresistance of ovarian cancer mainly through activating HR DNA repair and NHEJ DNA repair; also, TGFBI activate PI3K/Akt pathway to inhibit cell apoptosis and facilitate chemoresistance (Fig. 6). Here, TGFBI is linked to ovarian cancer.